FGFR1 and neoplasm: These data were confirmed by the tumor weight at the experimental endpoint in each group, indicated by the fact the weight of tumor tissue (1.25 ± 0.35 g) in NT shRNA-pHEX6300 was significantly heavier than that (0.38 ± 0.2 g) in FGFR1 shRNA-pHEX6300 (p < 0.0001, two-tailed t-test) that was significantly increased by ectopic expression of LDHA to 2.01 ± 0.39 g in FGFR1 shRNA-LDHA (p < 0.0001, two-tailed t-test) (Figure 5(b)).